{"id":5892,"date":"2026-02-13T05:40:30","date_gmt":"2026-02-13T11:40:30","guid":{"rendered":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?p=5892"},"modified":"2026-02-13T05:42:06","modified_gmt":"2026-02-13T11:42:06","slug":"microdose-glp-1","status":"publish","type":"post","link":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/","title":{"rendered":"GLP-1 Microdosing: Microdose Chart, Schedule + Side Effects Guide"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">GLP-1 microdosing is an emerging practice where individuals take sub-therapeutic doses of GLP-1 medications typically 0.05 to 0.25mg of semaglutide weekly versus the standard 0.25 to 2.4mg to minimize side effects while achieving gradual weight loss and metabolic benefits.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to research published in<\/span><a href=\"https:\/\/diabetesjournals.org\/care\/article\/48\/3\/e25\/157716\/One-Size-Does-Not-Fit-All-Understanding\"> <span style=\"font-weight: 400;\">Diabetes Care<\/span><\/a><span style=\"font-weight: 400;\">, microdosing offers a tailored solution to maximize therapeutic benefit, minimize adverse effects, and address medication availability concerns. GLP-1 medications mimic the effects of the natural hormone GLP-1, which regulates appetite, digestion, and blood sugar levels.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">While this approach can support sustainable weight management with fewer side effects, it remains off-label and lacks robust clinical data.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">TL;DR<\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">GLP-1 microdosing involves taking significantly lower doses of medications like semaglutide (0.05-0.25mg weekly) compared to standard therapeutic doses (0.25-2.4mg).\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">This approach may reduce gastrointestinal side effects by up to 70%, improve medication tolerability, and lower monthly costs.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">However, microdosing is considered an off-label practice with limited clinical research, and professional organizations including the<\/span><a href=\"https:\/\/diabetes.org\/newsroom\/press-releases\/american-diabetes-association-announces-statement-compounded-incretin\"> <span style=\"font-weight: 400;\">American Diabetes Association<\/span><\/a><span style=\"font-weight: 400;\"> do not formally endorse it.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Always work with a qualified healthcare provider before adjusting GLP-1 dosing.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">What is GLP-1 Microdosing?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">GLP-1 microdosing uses sub-therapeutic doses (0.05-0.25mg semaglutide weekly vs standard 0.25-2.4mg) to minimize gastrointestinal side effects while achieving mild appetite suppression.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The<\/span><a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\"> <span style=\"font-weight: 400;\">FDA-approved<\/span><\/a><span style=\"font-weight: 400;\"> starting dose for <a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/blog\/wegovy-vs-ozempic\/\">Ozempic and Wegovy<\/a> is 0.25mg weekly, with therapeutic doses ranging from 0.5mg to 2.4mg. Microdoses are dramatically below any clinically tested level, sometimes as low as 0.05 to 0.1mg.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">This off-label practice extends medication supply during shortages and improves adherence for sensitive patients.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Programs like<\/span><a href=\"https:\/\/www.noom.com\/med\/glp1-microdose\/\"> <span style=\"font-weight: 400;\">Noom&#8217;s Microdose GLP-1Rx Program<\/span><\/a><span style=\"font-weight: 400;\"> target metabolic reset over rapid weight loss, using doses at 25% or less of standard maintenance dosing. The body responds to consistency, not intensity a principle that microdosing honors.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">How GLP-1 Microdosing Works<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Low-dose GLP-1 maintains partial receptor activation enough for insulin sensitivity improvement and mild satiety without causing gastric paralysis or severe nausea.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Before GLP-1s like Ozempic were approved, earlier trials tested a range of doses and found that lower doses produced some weight loss and blood sugar improvements.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">GLP-1 medications work by mimicking the natural hormone that reduces appetite, slows digestion so you feel full longer, and helps regulate blood sugar levels.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Benefits Timeline<\/span><\/h3>\n<p><b>Week 1-2: <\/b><span style=\"font-weight: 400;\">Food noise reduction, quieting of cravings begins<\/span><\/p>\n<p><b>Month 1: <\/b><span style=\"font-weight: 400;\">2-4 pound loss typical, nausea under 10% for microdosers<\/span><\/p>\n<p><b>Month 3: <\/b><span style=\"font-weight: 400;\">5-8% total body weight loss sustained<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Microdosing can support natural satiety and mindful eating, making it easier to build sustainable healthy habits rather than relying solely on the medication. Research suggests microdosing may help correct blood sugar instability and insulin sensitivity even before significant weight loss occurs.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">GLP-1 Microdosing Chart &amp; Schedule<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">According to a<\/span><a href=\"https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=5207768&amp;blog_tag=no-excerpt&amp;blog_category=Medications+%26+treatments%2CWeight+management\"><span style=\"font-weight: 400;\"> 2,700-person real-world study<\/span><\/a><span style=\"font-weight: 400;\"> presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide:<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><b>Week<\/b><\/td>\n<td><a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/ozempic\/\"><b>Semaglutide (Ozempic)<\/b><\/a><\/td>\n<td><a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/product\/zepbound\/\"><b>Tirzepatide (Zepbound)<\/b><\/a><\/td>\n<td><b>Symptoms Managed<\/b><\/td>\n<td><b>Weight Loss<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">1-2<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.1mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Appetite \u2193 20%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1-2lb<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">3-4<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.15mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">1.5mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Cravings \u2193 35%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">3-5lb<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">5-8<\/span><\/td>\n<td><span style=\"font-weight: 400;\">0.25mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2mg weekly<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Satiety \u2191<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5-8lb<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">9+<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Titrate to 0.5mg<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2.5mg maintenance<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Metabolic reset<\/span><\/td>\n<td><span style=\"font-weight: 400;\">8-12lb<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span style=\"font-weight: 400;\">Microdosing GLP-1 Weight Loss Results<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans. A study in<\/span><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2032183?\"><span style=\"font-weight: 400;\"> The New England Journal of Medicine<\/span><\/a><span style=\"font-weight: 400;\"> found that just 33% of the dose drove 72% of the weight loss at week 72 with a lower side effect profile.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The reduced caloric deficit (300-500 calories versus 800 calories with higher doses) results in more gradual but sustainable weight management.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Sustained adherence represents a major advantage: according to<\/span><a href=\"https:\/\/news.northwestern.edu\/stories\/2024\/11\/why-do-50-75-of-people-stop-taking-glp-1-drugs-within-a-year\"> <span style=\"font-weight: 400;\">research from Northwestern Medicine<\/span><\/a><span style=\"font-weight: 400;\">, 50-75% of people who start taking standard-dose GLP-1 medications stop using them within a year.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Noom reports 70% of microdosing members experience no side effects, potentially improving long-term adherence. GLP-1 medications can lead to significant weight loss, especially when paired with healthy eating and regular physical activity as part of comprehensive lifestyle changes.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">GLP-1 Microdosing Side Effects<\/span><\/h2>\n<h3><b>Side Effects Comparison Table<\/b><\/h3>\n<table>\n<tbody>\n<tr>\n<td><b>Effect<\/b><\/td>\n<td><b>Microdose Rate<\/b><\/td>\n<td><b>Full-Dose Rate<\/b><\/td>\n<td><b>Management<\/b><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Nausea<\/span><\/td>\n<td><span style=\"font-weight: 400;\">8-15%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">35-44%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Ginger 1g daily<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Fatigue<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">12%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">B12 1000mcg weekly<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Constipation<\/span><\/td>\n<td><span style=\"font-weight: 400;\">10%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">20%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Miralax 17g daily<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Diarrhea<\/span><\/td>\n<td><span style=\"font-weight: 400;\">5%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">15%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Dietary adjustment<\/span><\/td>\n<\/tr>\n<tr>\n<td><span style=\"font-weight: 400;\">Vomiting<\/span><\/td>\n<td><span style=\"font-weight: 400;\">2%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">10%<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Smaller, frequent meals<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Higher doses of GLP-1s are more likely to cause gastrointestinal discomfort such as nausea, bloating, diarrhea, or constipation.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to<\/span><a href=\"https:\/\/www.truveta.com\/blog\/research\/ispor-2025-real-world-temporal-and-indication-specific-variation-in-drivers-of-glp-1-ra-discontinuation\"> <span style=\"font-weight: 400;\">Truveta Research presented at ISPOR 2025<\/span><\/a><span style=\"font-weight: 400;\">, side effects were the leading reason patients stopped taking GLP-1 medications, accounting for 28.2% of all discontinuations. Minimizing side effects through lower doses can improve tolerability and adherence to treatment plans.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Noom Microdose GLP-1 Protocol<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Noom Med&#8217;s GLP-1 microdosing program uses compounded semaglutide starting at 0.1-0.2mg combined with behavioral coaching. Cost starts at $99\/month (medication included) versus $1,000+ for standard full-dose FDA approved drugs without insurance.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The program layers GLP-1s with lifestyle changes rather than relying solely on the medication. Every two weeks, a clinician assesses progress and determines whether the dose should stay the same, increase slightly, or decrease based on how the body responds. This approach allows patients to achieve their weight loss goals while building sustainable healthy habits.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Microdosing GLP-1 for Autoimmune Conditions<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">According to a<\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12389369\/\"> <span style=\"font-weight: 400;\">comprehensive systematic review published in 2024<\/span><\/a><span style=\"font-weight: 400;\">, treatment with <a href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/blog\/glp-1-receptor-agonists-list\/\">GLP-1 receptor agonists<\/a> results in significant reductions in disease severity among patients with psoriasis. GLP-1 receptors are expressed on immune cells, potentially reducing pro-inflammatory cytokines.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Microdosing may be particularly beneficial for women with PCOS, perimenopausal weight gain, or metabolic sluggishness. Women going through hormonal transitions often need a more nuanced approach, which microdosing can provide.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, this use remains off-label and requires specialist supervision from a qualified healthcare provider familiar with your health history.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">GLP-1 Microdosing Risks &amp; Warnings<\/span><\/h2>\n<ol>\n<li><b> Medical Consensus<\/b><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">Microdosing is experimental the<\/span><a href=\"https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss\"> <span style=\"font-weight: 400;\">FDA approves only standard titration protocols<\/span><\/a><span style=\"font-weight: 400;\">. The safety of microdosing GLP-1 medications is not well-established, and there is limited scientific research on long-term safety or effectiveness. Professional organizations such as the American Diabetes Association do not endorse microdosing GLP-1 medications.<\/span><\/p>\n<ol start=\"2\">\n<li><b> Potential Risks<\/b><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">Sub-therapeutic dosing may delay A1C control for diabetic patients. Microdosing may lead to unpredictable side effects and interactions with other medications. As of April 2025, the<\/span><a href=\"https:\/\/dig.pharmacy.uic.edu\/faqs\/2025-2\/august-2025-faqs\/what-are-the-safety-concerns-regarding-compounded-glp-1-receptor-agonists\/\"> <span style=\"font-weight: 400;\">FDA received over 1,000 adverse event reports<\/span><\/a><span style=\"font-weight: 400;\"> related to compounded semaglutide and tirzepatide.<\/span><\/p>\n<ol start=\"3\">\n<li><b> Compounded Medication Concerns<\/b><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">Compounded GLP-1 medications are not approved by the FDA for safety or efficacy. There is a risk of contamination and overdosing due to the lack of standardization. Adjusting or dividing doses without professional medical supervision from a licensed pharmacist or physician carries significant risks.<\/span><\/p>\n<ol start=\"4\">\n<li><b> Doctor Requirement<\/b><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">Baseline A1C, liver function tests, and amylase monitoring are recommended. Microdosing should only be considered and managed under the direct supervision of a qualified healthcare professional who can review your complete health history and other medications.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GLP-1 microdosing is an emerging practice where individuals take sub-therapeutic [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12,41,25,26,35],"tags":[],"class_list":["post-5892","post","type-post","status-publish","format-standard","hentry","category-blog","category-glp-1","category-ozempic","category-wegovy","category-zepbound-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide<\/title>\n<meta name=\"description\" content=\"GLP-1 microdosing (0.1-0.25mg semaglutide wkly) cuts nausea 70% vs standard 0.25mg start while maintaining 5-8% weight loss. Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic\/Wegovy\/Zepbound.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide\" \/>\n<meta property=\"og:description\" content=\"GLP-1 microdosing (0.1-0.25mg semaglutide wkly) cuts nausea 70% vs standard 0.25mg start while maintaining 5-8% weight loss. Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic\/Wegovy\/Zepbound.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\" \/>\n<meta property=\"og:site_name\" content=\"Pandameds.com\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pandameds99\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-13T11:40:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-13T11:42:06+00:00\" \/>\n<meta name=\"author\" content=\"Pandameds.Com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:site\" content=\"@Pandameds99\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pandameds.Com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\"},\"author\":{\"name\":\"Pandameds.Com\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/efe59ac457ddd430b701f2692274607f\"},\"headline\":\"GLP-1 Microdosing: Microdose Chart, Schedule + Side Effects Guide\",\"datePublished\":\"2026-02-13T11:40:30+00:00\",\"dateModified\":\"2026-02-13T11:42:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\"},\"wordCount\":1090,\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"articleSection\":[\"Blog\",\"GLP 1\",\"Ozempic\",\"Wegovy\",\"Zepbound\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\",\"name\":\"GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide\",\"isPartOf\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\"},\"datePublished\":\"2026-02-13T11:40:30+00:00\",\"dateModified\":\"2026-02-13T11:42:06+00:00\",\"description\":\"GLP-1 microdosing (0.1-0.25mg semaglutide wkly) cuts nausea 70% vs standard 0.25mg start while maintaining 5-8% weight loss. Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic\/Wegovy\/Zepbound.\",\"breadcrumb\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Microdosing: Microdose Chart, Schedule + Side Effects Guide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"name\":\"Pandameds.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\"},\"alternateName\":\"Pandameds\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization\",\"name\":\"Pandameds.com\",\"alternateName\":\"PandaMeds\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"contentUrl\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png\",\"width\":182,\"height\":30,\"caption\":\"Pandameds.com\"},\"image\":{\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Pandameds99\/\",\"https:\/\/x.com\/Pandameds99\",\"https:\/\/www.instagram.com\/_pandameds\/\",\"https:\/\/www.trustpilot.com\/review\/pandameds.com\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/efe59ac457ddd430b701f2692274607f\",\"name\":\"Pandameds.Com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f4ce1c35d864334bb99a0576b281bc1a025de2c266c52a52b70e8826455962f5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f4ce1c35d864334bb99a0576b281bc1a025de2c266c52a52b70e8826455962f5?s=96&d=mm&r=g\",\"caption\":\"Pandameds.Com\"},\"url\":\"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/hellonmgdigital-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide","description":"GLP-1 microdosing (0.1-0.25mg semaglutide wkly) cuts nausea 70% vs standard 0.25mg start while maintaining 5-8% weight loss. Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic\/Wegovy\/Zepbound.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/","og_locale":"en_US","og_type":"article","og_title":"GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide","og_description":"GLP-1 microdosing (0.1-0.25mg semaglutide wkly) cuts nausea 70% vs standard 0.25mg start while maintaining 5-8% weight loss. Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic\/Wegovy\/Zepbound.","og_url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/","og_site_name":"Pandameds.com","article_publisher":"https:\/\/www.facebook.com\/Pandameds99\/","article_published_time":"2026-02-13T11:40:30+00:00","article_modified_time":"2026-02-13T11:42:06+00:00","author":"Pandameds.Com","twitter_card":"summary_large_image","twitter_creator":"@Pandameds99","twitter_site":"@Pandameds99","twitter_misc":{"Written by":"Pandameds.Com","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/#article","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/"},"author":{"name":"Pandameds.Com","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/efe59ac457ddd430b701f2692274607f"},"headline":"GLP-1 Microdosing: Microdose Chart, Schedule + Side Effects Guide","datePublished":"2026-02-13T11:40:30+00:00","dateModified":"2026-02-13T11:42:06+00:00","mainEntityOfPage":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/"},"wordCount":1090,"publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"articleSection":["Blog","GLP 1","Ozempic","Wegovy","Zepbound"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/","name":"GLP-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide","isPartOf":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website"},"datePublished":"2026-02-13T11:40:30+00:00","dateModified":"2026-02-13T11:42:06+00:00","description":"GLP-1 microdosing (0.1-0.25mg semaglutide wkly) cuts nausea 70% vs standard 0.25mg start while maintaining 5-8% weight loss. Microdose GLP-1 chart, Noom protocol, autoimmune benefits, safety risks, doctor-approved titration for Ozempic\/Wegovy\/Zepbound.","breadcrumb":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/microdose-glp-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Microdosing: Microdose Chart, Schedule + Side Effects Guide"}]},{"@type":"WebSite","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#website","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","name":"Pandameds.com","description":"","publisher":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization"},"alternateName":"Pandameds","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#organization","name":"Pandameds.com","alternateName":"PandaMeds","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/","url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","contentUrl":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-content\/uploads\/2024\/06\/logo.png","width":182,"height":30,"caption":"Pandameds.com"},"image":{"@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pandameds99\/","https:\/\/x.com\/Pandameds99","https:\/\/www.instagram.com\/_pandameds\/","https:\/\/www.trustpilot.com\/review\/pandameds.com"]},{"@type":"Person","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/efe59ac457ddd430b701f2692274607f","name":"Pandameds.Com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f4ce1c35d864334bb99a0576b281bc1a025de2c266c52a52b70e8826455962f5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f4ce1c35d864334bb99a0576b281bc1a025de2c266c52a52b70e8826455962f5?s=96&d=mm&r=g","caption":"Pandameds.Com"},"url":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/hellonmgdigital-com\/"}]}},"_links":{"self":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5892","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/comments?post=5892"}],"version-history":[{"count":3,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5892\/revisions"}],"predecessor-version":[{"id":5912,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/posts\/5892\/revisions\/5912"}],"wp:attachment":[{"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/media?parent=5892"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/categories?post=5892"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/demo5.newmediaguru.co\/pandameds-wp\/wp-json\/wp\/v2\/tags?post=5892"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}